Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice
Braz. j. med. biol. res; 53 (11), 2020
Sensory neuropathy is a dose-limiting side effect of oxaliplatin-based cancer treatment. This study investigated the antinociceptive effect of amifostine and its potential neuroprotective mechanisms on the oxaliplatin-related peripheral sensory neuropathy in mice. Oxaliplatin (1 mg/kg) was injected intra...
Amifostina/uso terapéutico, Antineoplásicos/toxicidad, Hiperalgesia/inducido químicamente, Hiperalgesia/tratamiento farmacológico, Hiperalgesia/prevención & control, Oxaliplatino, Enfermedades del Sistema Nervioso Periférico/inducido químicamente, Enfermedades del Sistema Nervioso Periférico/prevención & control